Verition Fund Management’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$348K Buy
2024
Q4
$163K Buy
2024
Q3
$152K Sell
2024
Q2
$229K Buy
2023
Q2
Sell
2023
Q1
$155K Buy